MIRA INFORM REPORT

 

 

Report Date :

29th December, 2006

 

IDENTIFICATION DETAILS

 

Name :

APOTECNIA SA

 

 

Registered Office :

Carretera  De Zeneta N 149, 30858  Totana  (Murcia)

 

 

Country :

Spain

 

 

Financials (as on) :

31.12.2005

 

 

Date of Incorporation :

09/03/1984

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture of basic pharmaceutical products

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


Company Name

 

APOTECNIA SA

 

 

TAX NUMBER

 

A28913283

 

 

Identification and Characteristics

 

COMPANY SITUATION:                     REACTIVATION OF THE COMPANY

Tax Number                                     A28913283

NAME                                                APOTECNIA SA

BUSINESS ADDRESS                        CARRETERA  DE ZENETA N 149

Postcode                                          30858  TOTANA  (MURCIA)

FORMER ADDRESS                           POLIGONO  INDUSTRIAL SILVOTA, 22

Postcode                                          33420  POSADA  (ASTURIAS (OVIEDO))

TELEPHONE                                      968368303

FAX                                                  968854361

LEGAL FORM                                    JOINT STOCK COMPANY

DATE FOUNDED                                09/03/1984

CAPITAL                                           120.202,42 Euros

PAID-UP CAPITAL                             120.202,42 Euros

NUMBER OF EMPLOYEES                 50

ACTIVITY                                          1254100 - Mfg. of basic pharmaceutical products

CNAE                                                2441 - Manufacture of basic pharmaceutical products

EXPORT COMPANY                          YES

IMPORT COMPANY                           YES

 

 

Synthesis

 

FINANCIAL SITUATION  (Year ending: 31/12/2005)

                                                                 

    TREASURY                                             9/9       Excellent

    DEBT                                                      9/9       Nil

INCIDENTS

                                                                 

    COMMITMENTS                                      9/9       Respected

    INCIDENTS                                             9/9       None or Negligible

PREVIOUS EXPERIENCE

                                                                 

    PREVIOUS EXPERIENCE                               7/9       Normal

 

 

Credit Appraisal

 

CREDIT ACCORDING TO OBJECTIVE DATA (From 0 to 500.000,00 Euros):

FAVOURABLE TOWARDS 14.424,29  Max. Euros

SOLVENCY RATING:

14/20 (BASED ON HOMOGENEOUS FORMULATION)

Analysis made on 22/11/2006

 

 

Financial Elements

    

Figures given in  Euros

 

Balance sheet 

2.003 (12)

Balance sheet 

2.004  (12)

Balance sheet 

2.005  (12)

ADDED VALUE

-644,03

-110,66

-108,99

BUSINESS RESULT

-2.587,07

821,73

-68,75

OWN FUNDS

115.259,78

116.081,51

116.012,76

DEBT

25.297,80

25.267,40

25.266,15

TOTAL ASSET

140.557,58

141.348,91

141.278,91

 

 

Added value grew by  1,51%  compared with the previous year. Shareholders equity are  116.012,76  Euros  for an indebtedness of  25.266,15  Euros  .

The result  -68,75  Euros  means financial profitability of  -0,06%  and economic profitability of  -0,05% . This result means growth of  -108,37%  compared with the  2.004 .

 

THE FIGURES FOR THE LAST BALANCE SHEET ARE RELEVANT:

SOURCE: FROM THE MERCANTILE REGISTER

DATE: 31/10/2006

 

 

Comparative Sector Analysis

 

 

Company

Sector

Difference

 

(2.005)

 

 

% of PRODUCTION VALUE

 

 

 

   SALES

 

 99,05

-99,05

   ADDED VALUE

 

 35,40

-35,40

   BUSINESS RESULT

 

 4,65

-4,65

% OF TOTAL ASSETS

 

 

 

   OWN FUNDS

 82,12

 56,35

 25,77

   DEBT

 17,88

 43,65

-25,77

 

Compared sector (CNAE):   244 - Fabricación de productos farmacéuticos

Number of companies:   22

Size (Sales Figure):   2.800.000,00 - 7.000.000,00 Euros

 

The company’s own resources are  82,12% ,  25,77% above the mean for the sector.

The company’s outside resources are  17,88% ,  25,77% below the mean for the sector.

 

 

Legal Actions

 

No legal incidences registered for this company in the official source

No claims registered for this company in the official sources

AFFECTED BY:  No significant elemento

 

 

Main Board members, Directors and Auditor

 

Position

Surname and name

Date of appointment

SOLE ADMINISTRATOR

ARIAS AGUILAR GERARDO UBALDO

19/02/2003

 

 

Financial Links

 

Shareholders

Company Name

CIF/Country

 

Source

Information Date

ASTURPHARMA SA

A33070988

100,00%   

OWN SOURCES

09/10/2006

 

 

Proceedings published in the B.O.R.M.E. (Official Mercantile Register Gazette)

 

Proceedings

Date

Notice Num.

Mercantile Reg.

Registration of accounts  (2005) 

21/11/2006

912069

MURCIA

Change of adress

29/09/2006

474105

MURCIA

Appointments

15/02/2006

081599

ASTURIAS (OVIEDO)

Registration of accounts  (2004) 

08/02/2006

056142

ASTURIAS (OVIEDO)

Registration of accounts  (2003) 

25/08/2004

246111

ASTURIAS (OVIEDO)

  

 

Press articles

 

22/06/2006            LA NUEVA ESPANA       LEGAL ANNOUNCE

LA JUNTA GRAL. UNIVERSAL DE ESTA SDAD. CELEBRADA EL DIA 10/03/06 ACORDO POR UNANIMIDAD TRASLADAR EL DOMICILIO SOCIAL A LA CARRETERA DE ZENETA, N. 149, EL RAIGUERO, LA VILLA, BENIEL (MURCIA).

 

26/01/2006            LA NUEVA ESPANA       GENERAL INFORMATION

EL GRUPO INDUSTRIAL FARMACEUTICO ASTURPHARMA HA ADQUIRIDO UNA PLANTA DE FA BRICACION EN ZENETA (MURCIA), HASTA AHORA PROPIEDAD DE LOS LABORATORIOS ITA LIANOS RECORDATI. LA OPERACION, POR UN IMPORTE DE 13 MM. DE EUROS, HA SIDO ACOMETIDA POR APOTECNIA, UNA SDAD. DEL GRUPO ASTURPHARMA. LA ADQUISICION DE LA PLANTA MURCIANA DE RECORDATI PERMITIRA AL GRUPO ASTURPHARMA AMPLIAR SU GAMA DE PRODUCTOS. LA INVERSION DE APOTECNIA EN MURCIA INCLUYE LA ADQUISI CION TANTO DE LOS ACTIVOS MATERIALES COMO DE LAS PATENTES DE FABRICACION QUE RECORDATI VENIA PRODUCIENDO EN SU FABRICA ESPAŃOLA.

 

 

Complementary Information

 

01/03/06 BLOQUE DE INVESTIGACION:

- Actividad: planta de principios activos farmaceuticos.

- Domicilio Social: Pol. Ind. Silvota, 22 Posada (33424) ASTURIAS.

oficina en zona industrial.

- El total de socios asciende a 1.

- Realiza transacciones intracomunitarias de sus ventas y compras con

todo el mundo.

----------------------------------------------------------------------

El bloque de Investigacion no esta sujeto a actualizaciones sistemati-

cas. Los datos mostrados fueron aportados por las fuentes consultadas

en la fecha del encabezamiento.

 

 

The information on the last account contained in this report is extracted from the Mercantile Register file of the legal address of the Company and dated 31/10/2006

 

 

Balance Sheet (ASSETS)

 

(Figures given in  Euros)

31/12/2003 (12)

31/12/2004 (12)

31/12/2005 (12)

 

A) DUE FROM SHAREHOLDERS FOR UNCALLED CAPITAL

 

 

 

 

B) FIXED ASSETS

 

 

 

 

I. Establishment expenses

 

 

 

 

II. Intangible assets

 

 

 

 

III. Tangible assets

 

 

 

 

IV. Financial assets

 

 

 

 

V. Owners equity

 

 

 

 

VI. Long term trade liabilities

 

 

 

 

C) DEFERRED EXPENSES

 

 

 

 

D) CURRENT ASSETS

140.557,58

141.348,91

141.278,91

 

I. Not paid in shareholder capital

 

 

 

 

II. Inventory

 

 

 

 

III. Debtors

137.385,86

138.329,55

38.379,53

 

IV. Short term financial assets

59,46

59,58

100.052,68

 

V. Short term owners equity

 

 

 

 

VI. Cash

3.112,26

2.959,78

2.846,70

 

VII. Prepaid expenses and accrued income

 

 

 

 

ASSETS (A + B + C + D)

140.557,58

141.348,91

141.278,91

 

 

Balance Sheet (LIABILITIES)

 

(Figures given in  Euros)

31/12/2003 (12)

31/12/2004 (12)

31/12/2005 (12)

 

A) SHAREHOLDERS EQUITY

115.259,78

116.081,51

116.012,76

 

I. Capital

120.202,42

120.202,42

120.202,42

 

II. Premium share account

 

 

 

 

III. Revaluation reserve

 

 

 

 

IV. Reserves

 

 

 

 

V. Prior year earnings

-2.355,57

-4.942,64

-4.120,91

 

VI. Prior year profit or losses

-2.587,07

821,73

-68,75

 

VII. Dividend paid during the year

 

 

 

 

VIII. Own shares for change in capital

 

 

 

 

B) DEFERRED INCOME

 

 

 

 

C) PROVISIONS FOR LIABILITIES AND EXPENSES

 

 

 

 

D) LONG TERM LIABILITIES

22.754,32

22.754,32

22.754,32

 

E) SHORT TERM LIABILITIES

2.543,48

2.513,08

2.511,83

 

F) SHORT TERM PROVISIONS FOR LIABILITIES AND EXPENSES

 

 

 

 

LIABILITIES (A + B + C + D + E + F)

140.557,58

141.348,91

141.278,91

 

 

Profit and Loss Account

 

(Figures given in  Euros)

31/12/2003 (12)

31/12/2004 (12)

31/12/2005 (12)

 

A) EXPENSES (A.1 a A.15)

 

 

 

 

A.1 Operating Expenses

 

 

 

 

A.3. Labor cost

 

 

 

 

A.3. Assets depreciation

 

 

 

 

A.4. Variance in provision for current assets

 

 

 

 

A.5. Other operating costs

644,03

110,66

108,99

 

A.I. OPERATING RESULT (B.1-A.1-A.2-A.3-A.4-A.5)

 

 

 

 

A.6. Financial expenses

 

 

 

 

A.7. Variation in financial investments provision

 

 

 

 

A.8. Exchange losses

 

 

 

 

A.II. POSITIVE FINANCIAL RESULTS (B.2+B.3-A.6-A.7-A.8)

 

 

 

 

A.III. PROFIT FROM ORDINARY ACTIVITIES (A.I+A.II-B.I-B.II)

 

 

 

 

A.9. Variation in provision in fixed assets

 

 

 

 

A.10. Losses in fixed assets

 

 

 

 

A.11. Losses from shares and bonds

 

 

 

 

A.12. Extraordinary charges

 

 

 

 

A.13. Prior year’s expenses and losses

2.133,35

 

0,03

 

A.IV. POSITIVE EXTRAORDINARY RESULT (B.4+B.5+B.6+B.7+B.8-A.9-A.10-A.11-A.12-A.13)

 

 

3,22

 

A.V. EARNINGS / LOSS BEFORE TAXES (A.III+A.IV-B.III-B.IV)

 

 

 

 

A.14. Corporate Taxes

33,75

-932,39

-37,02

 

A.15. Other taxes

 

 

 

 

A.VI. YEAR END RESULT (PROFIT) (A.V-A.14-A.15)

 

821,73

 

 

B) INCOMES (B.1 a B.8)

 

 

 

 

B.1. Operating income

 

 

 

 

B.I. OPERATING LOSSES (A.1+A.2+A.3+A.4+A.5-B.1)

644,03

110,66

108,99

 

B.2. Financial Income

 

 

 

 

B.3. Gains on exchange

 

 

 

 

B.II. FINANCIAL LOSSES (A.6+A.7+A.8-B.2-B.3)

 

 

 

 

B.III. LOSSES FROM ORDINARY ACTIVITIES (B.I+B.II-A.I-A.II)

644,03

110,66

108,99

 

B.4. Gains from disposal of fixed assets

 

 

 

 

B.5. Gains from dealing in own shares

 

 

 

 

B.6. Paid in surplus

 

 

 

 

B.7. Extraordinary income

224,06

 

 

 

B.8. Prior year’s income and profits

 

 

3,25

 

B.IV. EXTRAORDINARY LOSSES (A.9+A.10+A.11+A.12+A.13-B.4-B.5-B.6-B.7-B.8)

1.909,29

 

 

 

B.V. LOSS BEFORE TAXES (B.III+B.IV-A.III-A.IV)

2.553,32

110,66

105,77

 

B.VI. NET LOSS (B.V+A.14+A.15)

2.587,07

 

68,75

 

 

Main Ratios

 

(Figures given in  Euros)

2.003 (12)

2.004 (12)

2.005 (12)

 

ACTIVITY

 

 

 

 

Increase of the Sales Figures

 

 

 

 

Assets Turnover

 

 

 

 

Productivity

 

 

 

 

Increase of the Added Value

71,45

82,82

1,51

 

PROFITABILITY

 

 

 

 

Economic Profitability

-1,84

0,58

-0,05

 

Financial Profitability

-2,24

0,71

-0,06

 

Financial Expenses

 

 

 

 

BALANCE (IN DAYS OF SALES)

 

 

 

 

Customers’ Credit (In days of sales)

 

 

 

 

Suppliers’ Credit (In days of sales)

 

 

 

 

Working Capital (In days of sales)

 

 

 

 

Working Capital Requirement (In days of sales)

 

 

 

 

Treasury (In days of sales)

 

 

 

 

BALANCE

 

 

 

 

Working Capital

138.014,10

138.835,83

138.767,08

 

Working Capital Requirement

134.842,38

135.816,47

35.867,70

 

Treasury

3.171,72

3.019,36

102.899,38

 

Balance Ratio

 

 

 

 

SOLVENCY

 

 

 

 

Borrowing Ratio

18,00

17,88

17,88

 

Own / Permanent Funds

83,51

83,61

83,60

 

Payback Capacity

 

 

 

 

LIQUIDITY

 

 

 

 

General Liquidity

55,26

56,25

56,25

 

Immediate Liquidity

1,25

1,20

40,97

 


Sectorial Analysis

 

Summary of Assets, Liability & Equity

 

(Figures given in Percentages)

Company

Sector

Company

 

2.005

 

 

 

Assets

   DUE FROM SHAREHOLDERS FOR UNCALLED CAPITAL

 0,00

 0,00

 0,00

   FIXED ASSETS

 0,00

 41,19

-41,19

   ACCRUED EXPENSES

 0,00

 0,34

-0,34

   CURRENT ASSETS

 100,00

 58,47

 41,53

   TOTAL ASSETS

 100,00

 100,00

 0,00

 

Liabilities

   SHAREHOLDERS EQUITY

 82,12

 56,35

 25,77

   ACCRUED INCOME

 0,00

 0,20

-0,20

   RISK AND EXPENDITURE COVER

 0,00

 0,00

 0,00

   LONG-TERM CREDITORS

 16,11

 8,33

 7,78

   SHORT-TERM CREDITORS

 1,78

 35,12

-33,34

   SHORT-TERM RISK AND EXPENDITURE COVER

 0,00

 0,00

 0,00

   TOTAL LIABILITIES

 100,00

 100,00

 0,00

 

Ratios

 

(Figures given in )

Company

Ptile25

Medium

Ptile75

 

2.005

 

 

 

ACTIVITY

 

 

 

 

   Increase of the Sales Figures

 

-10,46

-0,08

 12,88

   Assets Turnover

 

 0,84

 1,14

 2,18

   Fixed Assets Turnover

 

 1,73

 3,44

 9,04

   Increase of the Added Value

 1,51

-5,49

 2,16

 25,99

PRODUCTIVITY

 

 

 

 

   Productivity

 

 1,24

 1,53

 1,84

   Change of Personnel Costs

 

-5,13

 8,57

 16,42

   Average Personnel Costs

 

 25.127,23

 29.434,94

 34.620,70

   Value Added by Employees

 

 33.831,91

 48.658,68

 51.819,81

CASH FLOW

 

 

 

 

   Cash Flow

-68,75

 141.079,72

 302.460,30

 481.357,54

   Operating Cash Flow

-108,99

 184.807,88

 333.778,80

 665.961,26

   Change in Cash Flow

-108,37

-19,95

 13,50

 33,11

PROFITABILITY

 

 

 

 

   Economic Profitability

-0,05

 1,83

 4,04

 8,63

   Financial Profitability

-0,06

 3,80

 8,89

 17,02

   Financial Expenses

 

 0,28

 0,71

 1,75

   Gross Economic Profitability

-0,08

 7,46

 10,97

 17,13

   Gross Financial Profitability

-0,09

 13,38

 24,17

 39,93

BALANCE (IN DAYS OF SALES)

 

 

 

 

   Customers’ Credit (In days of sales)

 

 54,16

 86,29

 109,36

   Suppliers’ Credit (In days of sales)

 

 0,00

 0,00

 79,72

   Working Capital (In days of sales)

 

 6,23

 42,23

 118,42

   Working Capital Requirement (In days of sales)

 

-7,42

 32,83

 69,28

   Treasury (In days of sales)

 

 0,88

 16,70

 37,83

   Operating Current Assets

 

 112,38

 148,01

 286,08

BALANCE

 

 

 

 

   Working Capital

 138.767,08

 64.204,17

 637.229,85

 1.290.019,99

   Working Capital Requirement

 35.867,70

-79.167,56

 329.104,20

 765.050,93

   Treasury

 102.899,38

 8.607,61

 157.325,09

 403.981,71

   Balance Ratio

 

 1,07

 1,40

 3,69

SOLVENCY

 

 

 

 

   Borrowing Ratio

 17,88

 36,90

 50,94

 68,26

   Own / Permanent Funds

 83,60

 79,59

 93,37

 99,13

   Payback Capacity

 

 0,20

 0,34

 0,41

   Long term Indebtedness

 16,11

 0,41

 2,48

 13,87

   Gearing

 121,78

 158,47

 205,09

 315,13

   Financing Basic Ratio

 1,00

 1,00

 1,00

 1,00

   Assets Guarantee

 5,59

 1,26

 1,65

 2,68

LIQUIDITY

 

 

 

 

   General Liquidity

 56,24

 1,05

 1,35

 2,38

   Immediate Liquidity

 40,97

 0,05

 0,31

 0,59

The date when this report was last updated is 22/11/2006.

 

This company was last displayed on 29/12/2006,

 it has been viewed 30 times in the last quarter  and 149 times in total .

 

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions